Last €3.46 EUR
Change Today -0.197 / -5.39%
Volume 0.0
EZB On Other Exchanges
Symbol
Exchange
New York
Munich
As of 2:56 AM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David C. Goldberg

Vice President of Corporate Development and Interim General Manager of Enzo Clinical Labs, Enzo Biochem Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

57$344,106
As of Fiscal Year 2013

Background*

Mr. David C. Goldberg serves as Vice President of Corporate Development and Interim General Manager of Enzo Clinical Labs of Enzo Biochem Inc. and Enzo Clinical Labs, Inc. Mr. Goldberg served as Senior Vice President of Enzo Clinical Labs at Enzo Biochem Inc. Mr. Goldberg served as Vice President of Business Development of Enzo Biochem Inc. since 1995. Prior to Enzo Biochem Inc. in 1985, he was employed at DuPont NEN Products and Gallard Schlesinger Industries where ...

Read Full Background

Corporate Headquarters*

527 Madison Avenue
New York, New York 10022

United States

Phone: 212-583-0100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
New York University
MS
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Salary$215,000
Total Annual Compensation$215,000

Stock Options*

All Other Compensation$29,183
Exercisable Options25,750
Unexercisable Options27,429
Total Number of Options53,179

Total Compensation*

Total Annual Cash Compensation$309,683
Total Short Term Compensation$215,000
Other Long Term Compensation$29,183
Total Calculated Compensation$344,106
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EZB:GR €3.46 EUR -0.197

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Justin C. Dearborn Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA
Merge Healthcare Incorporated
$347.5K
Robert A. Frist Jr.Co-Founder, Chairman of the Board, Chief Executive Officer and President
Healthstream Inc.
$265.6K
Franklin R. Witney Ph.D.Chief Executive Officer, President and Director
Affymetrix Inc.
$498.6K
Patrick J. Balthrop Sr.Chief Executive Officer, President, Director, Member of Executive Committee and Member of Strategy & Development Committee
Luminex Corporation
$700.0K
J. Boyd Douglas Chief Executive Officer, President and Executive Director
Computer Programs & Systems Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.